[Federal Register Volume 72, Number 161 (Tuesday, August 21, 2007)]
[Notices]
[Pages 46647-46648]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-4069]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Initial Review 
Group, Subcommittee G--Education.
    Date: September 11-12, 2007.
    Time: 8 a.m. to 4:45 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Gaithersburg Marriott Washingtonian Center, 204 Boardwalk 
Place, Gaithersburg, MD 20878.
    Contact Person: Sonya Roberson, PhD., Scientific Review 
Administrator, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, 6116 Executive 
Blvd., Room 8109, Bethesda, MD 20892, 301-594-1182, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, R25 Special Emphasis Panel (SEP).
    Date: September 11, 2007.
    Time: 5 p.m. to 7 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Gaithersburg Marriott Washingtonian Center, 204 Boardwalk 
Place, Gaithersburg, MD 20878.
    Contact Person: Jeannette F. Korczak, PhD., Scientific Review 
Administrator, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 6116 
Executive Blvd., Room 8115, Bethesda, MD 20892, 301-496-9767, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Oral Bioavailability Enhancement.
    Date: September 18, 2007.
    Time: 2 p.m. to 4 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6130 Executive Blvd., 
Conference Room C, Rockville, MD 20852. (Telephone Conference Call).
    Contact Person: Thomas M. Vollberg, PhD., Scientific Review 
Administrator, Special Review And Logistics Branch, Division of 
Extramural Activities, National Cancer Institute, 6116 Executive 
Blvd., Room 7142, Bethesda, MD 20892, 301-594-9582, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Clinical Studies SEP.
    Date: October 3-4, 2007.
    Time: 8 a.m. to 1 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: Majed M. Hamawy, PhD., MBA, Scientific Review 
Administrator, Research Programs Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 6116 
Executive Boulevard, Room 8135, Bethesda, MD 20852, 301-496-7565, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Clinical SEP 2.
    Date: October 4, 2007.
    Time: 1 p.m. to 2 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: Peter J. Wirth, PhD., Scientific Review 
Administrator, Research Programs Review Branch, Division of 
Extramural Activities, National Cancer Institute, 6116 Executive 
Boulevard, Room 8131, Bethesda, MD 20892-8328, 301-496-7565, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS).


[[Page 46648]]


    Dated: August 13, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-4069 Filed 8-20-07; 8:45 am]
BILLING CODE 4140-01-M